Jynneos

— THERAPEUTIC DISORDERS TREATED —
  • Vaccines

Jynneos Generic Name & Formulations

General Description

Smallpox and Monkeypox vaccine, live, non-replicating; contains 0.5–3.95×108 infectious units of MVA-BN live virus; per 0.5mL dose; susp for SC inj; preservative-free.

How Supplied

Single-dose vials—20

Manufacturer

Generic Availability

NO

Jynneos Indications

Indications

Prevention of smallpox and monkeypox disease in adults determined to be at high risk for smallpox or monkeypox infection.

Jynneos Dosage and Administration

Adult

Give by SC inj (preferably into deltoid). ≥18yrs: 2 doses (0.5mL each) given 4 weeks apart.

Children

<18yrs: not established.

Jynneos Contraindications

Not Applicable

Jynneos Boxed Warnings

Not Applicable

Jynneos Warnings/Precautions

Warnings/Precautions

Have appropriate medical treatment available to manage possible anaphylactic reactions. Immunocompromised. Vaccination may not protect all recipients. Pregnancy. Nursing mothers.

Jynneos Pharmacokinetics

See Literature

Jynneos Interactions

Jynneos Adverse Reactions

Adverse Reactions

Inj site reactions (eg, pain, swelling, redness, induration, itching), muscle pain, headache, fatigue, nausea, chills; severe allergic reactions.

Jynneos Clinical Trials

See Literature

Jynneos Note

Not Applicable

Jynneos Patient Counseling

See Literature